Clinical Trials Directory

Trials / Completed

CompletedNCT02344615

Nerve Stimulator Versus Ultrasound-guided Infraclavicular Block

A Randomized Comparison of Nerve Stimulator and Ultrasound-guided Infraclavicular Block for Upper Extremity Surgery

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
44 (estimated)
Sponsor
Cheju Halla General Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The investigators compared the postoperative analgesia of nerve stimulator-guided and ultrasound-guided infraclavicular block for upper extremity surgery.

Detailed description

Ultrasound (US)-guided peripheral nerve block has increased in popularity. It has many advantages such as improved success rate, faster onset time, fewer needle passes, shorter performance time, and reduced procedural pain and vascular puncture. However, there is no information about postoperative analgesia. Therefore, the investigators tested whether ultrasound-guided peripheral nerve block enhanced the postoperative analgesia for upper extremity surgery compared with nerve stimulator (NS) guidance.

Conditions

Interventions

TypeNameDescription
PROCEDURENS-guided infraclavicular blockPatients received a standard single injection infraclavicular block using the lateral sagittal approach of Klaastad. The infraclavicular brachial plexus is identified using an insulated needle connected to a nerve stimulator. Placement of the needle is considered adequate if motor response of radial nerve in the hand or wrist is still present at 0.2 - 0.5mA. Ropivacaine 0.5% 35ml is used.
PROCEDUREUS-guided infraclavicular blockInfraclavicular block is performed under ultrasound guidance. Linear probe is placed in a parasagittal positon below the clavicle medial to the coracoid process and adjusted to achieve a cross-sectional image of the axillary artery. Using in-plane technique, an 22-gauge insulated needle is advanced caudally and posteriorly to the axillary artery. Subsequently, 35 ml of 0.5% ropivacaine is incrementally injected.

Timeline

Start date
2014-05-01
Primary completion
2015-12-01
Completion
2015-12-01
First posted
2015-01-26
Last updated
2016-01-28

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02344615. Inclusion in this directory is not an endorsement.